Inactivated Influenza Vaccine
This vaccine is recommended for adults and children from six months and above, especially those having high risk of associated complications, such as children, senior citizens, those who are susceptible and those who are in influenza epidemic areas.
The vaccine can induce body to generate immunoreaction against influenza virus and can be used for prevention of infection caused by influenza virus.
Adult and children over 3 years of age: one dose of 0.5 ml.
Children from 6 to 36 months of age: one dose of 0.25 ml. For children who have not previously been vaccinated, a second dose should be given after an interval of at least 4 weeks.
As with all medicinal products this product may cause undesirable effects.
Local reactions: redness, swelling, pain, induration.
Sytemical reactions: fever, dizziness, shivering, fatigue, sweating, myalgia, arthralgia, pruritus, rash, headache. These reactions usually disappear within one or two days without treatment.
Reactions such as shock and eclampsia, vasculitis (inflammation of the blood vessels) with transient renal involvement, neurological disorders are rarely seen. If any unmentioned discomfort appeared, please seek medical help.
Pregnancy & Lactation
Influenza vaccine should be used during pregnancy only when clearly needed and possible advantages outweigh the potential risk of fetus.
There is no known contra-indication to the use of Influenza vaccine during lactation.
- Do not use in case that there is any crack in the container, the vaccine is degenerative, or there is big mass that cannot be disappeared by shaking.
- Administration must not be via vascular route.
- This product should be stored at places out of reach by children.
- Shake well before use. Do not shake vigorously.
- It should be used cautiously for patient with hypersensitivity history.
- It should not be mixed with other vaccines in the same container.
- As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.
- Application of immunosuppressors may decrease or inhibit immunization reactions. Person who is administrated globulin should be vaccinated the vaccine 1 month later.
Influenza vaccine should not be given to individuals with Guillain-Barre syndrome, bleeding disorder. Natural latex rubber of plunger stopper of the syringe has been associate with allergic reactions. Immunocompromised persons may not obtain the expected immune response. As with any vaccine, immunization with influenza vaccine may not protect 100% of susceptible individuals.